Acadian Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Acadian Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Hold	741	–	–	﹤0.01%	1604
2026 Q1	$238K	Buy	741 +112	+18%	+$34.6K	﹤0.01%	1540
2025 Q4	$184K	Buy	+629	New	+$117K	﹤0.01%	1534
2024 Q4	–	Sell	-1,189	Closed	-$68K	–	2049
2024 Q3	$68K	Buy	+1,189	New	+$64.2K	﹤0.01%	1720
2024 Q2	–	Sell	-82,254	Closed	-$5.02M	–	1879
2024 Q1	$5.02M	Sell	82,254 -15,795	-16%	-$709K	0.02%	466
2023 Q4	$2.18M	Buy	98,049 +2,417	+3%	+$43.5K	0.01%	652
2023 Q3	$2.45M	Sell	95,632 -7,249	-7%	-$137K	0.01%	635
2023 Q2	$1.77M	Buy	102,881 +9,787	+11%	+$150K	0.01%	728
2023 Q1	$1.13M	Buy	93,094 +2,859	+3%	+$121K	﹤0.01%	849
2022 Q4	$3.22M	Buy	90,235 +22,124	+32%	+$690K	0.02%	555
2022 Q3	$2.32M	Buy	68,111 +12,837	+23%	+$640K	0.01%	593
2022 Q2	$2.03M	Buy	+55,274	New	+$5.9M	0.01%	628

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management's PRAX Position: Q2 2026 in Review

Acadian Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 741 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Acadian Asset Management first reported a position in PRAX in Q2 2022 and has held it in 12 quarters since. The position peaked at $5.02M in Q1 2024. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Acadian Asset Management held 741 shares of Praxis Precision Medicines worth $246K as of Q2 2026.
Acadian Asset Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
Praxis Precision Medicines made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1604 holding.
Acadian Asset Management first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 12 quarters since.
Acadian Asset Management's Praxis Precision Medicines position peaked at $5.02M in Q1 2024.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.